Drug giant Pfizer scraps $212b merger with Allergan

US pharmaceutical giant Pfizer announces it is abandoning plans for a $212 billion merger with Botox maker Allergan, citing new US rules cracking down on tie-ups aimed at saving on taxes.

from Top Stories http://ift.tt/1Wc7Mo6